COMMUNIQUÉS West-GlobeNewswire

Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that Marc Elia, [...]
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
13/05/2024
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b [...]
Teknova Reports First Quarter 2024 Financial Results
13/05/2024
First quarter 2024 total revenue was $9.3 million, up 2% from prior year Launch of Build-Tek™ Custom Configurator Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13, 2024 (GLOBE NEWSWIRE [...]
Assure & Danam to Host Corporate Update Call & Webcast
13/05/2024
DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that [...]
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
13/05/2024
Cemacabtagene Ansegedleucel (Cema-Cel) Expanded CD19 Oncology Rights to Include all EU Member States and the United Kingdom, Reinforcing Company’s Conviction in the Unique Opportunity in Large B Cell Lymphoma (LBCL) and [...]
AVITA Medical Reports First Quarter Financial Results
13/05/2024
VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Akoya Biosciences Reports First Quarter 2024 Financial Results
13/05/2024
MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for the first quarter ending March 31, 2024. [...]
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024
CHARLOTTESVILLE, Va., May 13, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta [...]
A Pint for Kim Blood Drive Breaks State Record Fifth Year in a Row with More than 700 Donors Showing Up to Give Blood
13/05/2024
National grassroots movement has secured tens of thousands of pints of blood, all in honor of a mom who lost her eight-year battle with rare cancer NAPERVILLE, Ill., May 13, 2024 (GLOBE NEWSWIRE) -- A Pint For Kim , a [...]
Claritas HealthTech Further Expands Global Presence with Entry into Brazil Focusing on its Solutions in Nuclear Medicine
13/05/2024
LONDON and NEW YORK and SAO PAULO, Brazil, May 13, 2024 (GLOBE NEWSWIRE) -- Claritas HealthTech (“Claritas”) , a healthcare technology company specializing in advanced medical image enhancement, reconstruction, and AI [...]
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
13/05/2024
Pain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment CLEVELAND, May 13, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a multicenter double-blind randomized, [...]
Spectrum Healthcare Resources awarded new 10-year contract to deliver health care for active duty and retired military personnel and families
13/05/2024
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Spectrum Healthcare Resources (Spectrum), a long-standing, trusted partner of the U.S. Department of Defense Military Health System, announces that it was awarded a 10-year [...]
Fagron shareholders approve all voting items at AGM and EGM
13/05/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 13 May 2024 – 7PM CET Fagron shareholders approve all voting items at AGM and EGM Fagron, the leading global player in pharmaceutical compounding, [...]
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
13/05/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – May 13, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today [...]
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
13/05/2024
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL 2036 Paris, May 13, 2024, 6pm CET AB Science SA (Euronext - FR0010557264 - AB [...]
AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036
13/05/2024
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET EUROPÉEN POUR LE MASITINIB DANS LE TRAITEMENT DE LA MASTOCYTOSE SÉVÈRE AVEC UNE PROTECTION JUSQU'EN 2036 Paris, 13 mai 2024, 18h AB Science SA (Euronext [...]
Safe signs a strategic partnership in the United States with a californian hospital group
13/05/2024
Safe signs a strategic partnership in the United States with a californian hospital group Expansion of presence in the United States, the leading spine market Fleurieux-sur-l’Arbresle - France – May 13, 2024 at 6 p.m . [...]
Safe signe un partenariat stratégique aux Etats-Unis avec un groupe d’hôpitaux californien
13/05/2024
Safe signe un partenariat stratégique aux Etats-Unis avec un groupe d’hôpitaux californien Élargissement de la présence aux Etats-Unis, premier marché du rachis Fleurieux-sur-l’Arbresle - France - le 13 mai 2024 à 18h [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
13/05/2024
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 13 mai 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général [...]

Pages